"86 Do sex-specific high sensitivity troponin cut points improve safety" by Connor Montgomery, Nicklaus P. Ashburn et al.
 

86 Do sex-specific high sensitivity troponin cut points improve safety and efficacy?

Document Type

Conference Proceeding

Publication Date

4-27-2024

Publication Title

Acad Emerg Med

Abstract

Background and Objectives: Data comparing the performance of sex-specific to non-sex-specific high-sensitivity cardiac troponin (hs-cTn) cut-points for diagnosing acute coronary syndrome (ACS) are limited. This study evaluated the safety (30-day cardiac death or myocardial infarction [MI]) and efficacy (rule-out rate) when using sex-specific vs. non-sex-specific (overall) 99th percentile hs-cTnT cut-points. Methods: We conducted a secondary analysis of the STOP-CP cohort, which prospectively enrolled adult ED patients with possible ACS across 8 U.S. sites (1/25/2017–9/6/2018). Participants with both 0- and 1-h hs-cTnT measures (Roche, Basel, Switzerland) less than the 99th percentile were classified into the rule-out group. The 99th percentile was defined using (1) a sex-specific strategy using a 99th percentile of 22?ng/L for males and 14?ng/L for females and (2) an overall strategy using a 99th percentile of 19?ng/L. The safety outcome was adjudicated cardiac death or MI at 30?days. Efficacy was determined by the proportion classified to the rule-out group. McNemar's test compared rule-out rates between strategies. Negative predictive values (NPV) with 95% confidence intervals were calculated and compared using a generalized score statistic. The net reclassification improvement (NRI) index further compared performance. Results: During the study period 1430 patients were enrolled, of which 45.8% (655/1430) were female and the mean age was 57.6?±?12.8?years. At 30?days, cardiac death or MI occurred in 12.8% (183/1430). The rule-out rate was lower when using sex-specific vs. overall cut-points (69.2% [990/1430] vs. 71.7% [1025/1430]; p?

Volume

31

Issue

S1

First Page

47

Share

COinS